Aug. 7 at 12:40 PM
$RVVTF I know the nearest opportunity for a catalyst is Bucillamine, but Revive should be setting aside a little time to see if they can capitalize on their Psilocybin intellectual property in the future, perhaps through partnership. Another study by US Veterans Administration.
Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression (PIVOT)
https://clinicaltrials.gov/study/NCT07226232